Ivan Hyep
Fortune : 3 M $ au 31/05/2026
Fortune : 3 M $ au 31/05/2026
Ivan Hyep is currently Chief Financial Officer & Treasurer at Bicara Therapeutics, Inc. since 2024.
Formerly, Mr. Hyep was Finance Director at MOMA Therapeutics, Inc. from 2019 to 2021 and Finance Manager at Bain Capital LP from 2006 to 2016.
Education includes an undergraduate degree from Bentley University and an MBA from Questrom School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BICARA THERAPEUTICS INC. 0,23 % | 21/05/2026 | 145 355 ( 0,23 % ) | 3 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BICARA THERAPEUTICS INC. | Directeur Financier/CFO | 01/03/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
MOMA Therapeutics, Inc.
MOMA Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for regenerative medicine employing injectable gel-based scaffolds | Directeur Financier/CFO | 01/03/2021 |
Bain Capital LP
Bain Capital LP Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | 10/01/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Bain Capital LP
Bain Capital LP Financial ConglomeratesFinance Provides investment services | Finance |
Bentley University
Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Questrom School of Business
Questrom School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MOMA Therapeutics, Inc.
MOMA Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for regenerative medicine employing injectable gel-based scaffolds | Health Technology |
Bicara Therapeutics, Inc.
Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national